search
Back to results

STI/HIV Intervention Behavioral Intervention Program

Primary Purpose

Sexually Transmitted Infections

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
STI/HIV Intervention Behavioral Intervention Program
Sponsored by
Madigan Army Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sexually Transmitted Infections focused on measuring STI, HIV, syphilis, gonorrhea, chlamydia, mycoplasma genitalium

Eligibility Criteria

18 Years - 30 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Age 18 - 30 years
  2. Army active duty or Army medical beneficiary
  3. Eligible to receive care at a military healthcare clinic for at least 12 months from enrollment
  4. HIV negative
  5. Not scheduled for military deployment or transfer within 3 months of enrolment
  6. Not pregnant, regardless of marital status
  7. Not trying to become pregnant or impregnate a partner, regardless of marital status
  8. Be classified as "high risk" either through a positive STI diagnosis in the last 180 days or has had STI screening during this timeframe.
  9. Self reports vaginal, oral, and/or anal sexual contact in the last 30 days.

Exclusion Criteria:

  1. Under 18 or over 30 years of age
  2. Not Army active duty or Army medical beneficiary
  3. Not eligible to receive care at a military healthcare clinic for study duration (next 12 months)
  4. HIV positive
  5. Military deployment or transfer scheduled within 3 months of enrollment
  6. Are pregnant, regardless of marital status
  7. Are trying to become pregnant or impregnate someone, regardless of marital status
  8. Has not had a positive STI diagnosis or STI screening within the last 180 days
  9. Does not self-report vaginal, anal, and/or oral sexual contact in the last 30 days

Sites / Locations

  • Ft. BraggRecruiting
  • Madigan Army Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Control Arm

Intervention Arm

Arm Description

Control Arm will will complete a total of three visits: Visit 1 (Day 1): Recruitment/Baseline Biological Testing, if needed; completion of baseline study surveys including Knowledge Assessment Monthly: Prevention Maintenance Intervention Messages from months 2-11 Visit 3 (Day 180): 6 Month Follow-up biological testing and study survey Visit 4 (Day 365): 12 Month Follow-up biological testing and study surveys

Intervention Arm will will complete a total of four visits: Visit 1 (Day 1): Recruitment/Baseline Biological Testing, if needed; completion of baseline study surveys including Knowledge Assessment Visit 2 (Day 2-30): Group Intervention Session, Feedback form, and post-intervention knowledge assessment (for intervention arm only) Monthly: Prevention Maintenance Intervention Messages from months 2-11 Visit 3 (Day 180): 6 Month Follow-up biological testing and study survey Visit 4 (Day 365): 12 Month Follow-up biological testing and study surveys

Outcomes

Primary Outcome Measures

Incident sexually transmitted infections
Biological testing for syphilis, chlamydia trachomatis, neisseria gonorrhea, mycoplasma genitalium, and HIV
Acceptability of the intervention
participant feedback and rating of the intervention session

Secondary Outcome Measures

Number of sexual partners
self-report by questionnaire
Proportion of sexual encounters protect by condom use
self-report by questionnaire

Full Information

First Posted
August 21, 2020
Last Updated
January 20, 2023
Sponsor
Madigan Army Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04547413
Brief Title
STI/HIV Intervention Behavioral Intervention Program
Official Title
Prospective Cohort Trial To Assess Acceptability and Efficacy of an Adapted STI/HIV Intervention Behavioral Intervention Program in a Population of US Army Personnel and Their Medical Beneficiaries - Execution Phase
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 4, 2020 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Madigan Army Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The hypothesis is that a behavioral intervention tool adapted for the US military population will be acceptable and associated with a decrease in incident sexually transmitted infection (STI)/HIV rates and high-risk sexual behaviors, and increased self-reported condom use compared to the standard of care at the Joint Base Lewis-McChord (JBLM) Preventive Medicine clinic and the Fort Bragg Department of Public Health (part of Womack Army Medical Center).
Detailed Description
This is the Execution Phase which will be conducted as a multi-site randomized controlled trial. A previous Formative Phase study was conducted under a separate protocol which has been completed with preliminary data indicating positive outcomes. Participants in both arms will meet the same inclusion/exclusion criteria and will be randomized into the intervention and control arms at a ratio of 1:1. The intervention arm will receive the KISS (Knocking out Infections through Safer sex and Screening) intervention program in addition to standard STI prevention counselling routinely provided by military medical treatment facilities. The control arm will receive only standard STI prevention counselling. Both arms will receive follow-up educational messages via short message service (SMS)/text messaging monthly for 10 months, and have follow-up study visits at 6 months and 12 months. The KISS intervention is a 2-hour, small group (6-12 individuals) class-based interactive, educational session based on Social Cognitive Theory and the Theory of Gender and Power. The intervention is an adaptation of the HORIZONS intervention, which has shown efficacy are reducing sexual risk behavior and incident STIs among adolescents in the USA. HORIZONS has been reviewed by the U.S. Centers for Disease Control (CDC) Prevention Synthesis Research team and designated a CDC top-tier (Tier I) evidence-based intervention (EBI). To enroll in the study, participants must be categorized as "high risk" as determined by a positive test for an STI within the previous 180 days or has had STI screening during this time frame (specifically gonorrhea (GC), chlamydia (CT), M. genitalium, syphilis and/or HIV). Study subjects will be recruited from Madigan Army Medical Center (Madigan) Preventive Medicine Clinic and the Womack Army Medical Center (Womack) Preventive Medicine Clinic in Ft. Bragg, North Carolina (NC). In addition, promotional flyers for recruitment will be placed in public areas on both bases, and will be promoted through approved social media channels. Subjects may also refer up to 5 friends or colleagues for screening. Participants enrolled in the intervention arm will complete a total of four visits and those in the control arm will complete a total of three visits. Over the course of the study, participants in both groups will be asked to provide biological specimens and complete knowledge/behavioral surveys three times (at baseline, 6 and at 12 months). Those in the intervention group will also attend the KISS EBI (Evidence Based Intervention) program. Both arms will receive monthly (months 2-11) follow up text messages, but the content will defer between the two arms. Those in the intervention arm, will receive SMS/text messages targeting prevention maintenance interventions (PMI) messages reiterating information received during the EBI session. Those in the control arm, will receive SMS/text messages that will contain general health information.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sexually Transmitted Infections
Keywords
STI, HIV, syphilis, gonorrhea, chlamydia, mycoplasma genitalium

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a randomized, controlled trial of a behavioral intervention designed to increase the use of safer sexual practices and to reduce incident STi rates. The intervention is a 2-hour class based program and therefore is not blinded. Outcome measures of sexual behavior and incident STIs will be measured at 6 and 12 months after the intervention.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
700 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Arm
Arm Type
No Intervention
Arm Description
Control Arm will will complete a total of three visits: Visit 1 (Day 1): Recruitment/Baseline Biological Testing, if needed; completion of baseline study surveys including Knowledge Assessment Monthly: Prevention Maintenance Intervention Messages from months 2-11 Visit 3 (Day 180): 6 Month Follow-up biological testing and study survey Visit 4 (Day 365): 12 Month Follow-up biological testing and study surveys
Arm Title
Intervention Arm
Arm Type
Active Comparator
Arm Description
Intervention Arm will will complete a total of four visits: Visit 1 (Day 1): Recruitment/Baseline Biological Testing, if needed; completion of baseline study surveys including Knowledge Assessment Visit 2 (Day 2-30): Group Intervention Session, Feedback form, and post-intervention knowledge assessment (for intervention arm only) Monthly: Prevention Maintenance Intervention Messages from months 2-11 Visit 3 (Day 180): 6 Month Follow-up biological testing and study survey Visit 4 (Day 365): 12 Month Follow-up biological testing and study surveys
Intervention Type
Behavioral
Intervention Name(s)
STI/HIV Intervention Behavioral Intervention Program
Other Intervention Name(s)
KISS (Knocking out Infections through Safer sex and Screening
Intervention Description
In addition to standard of care STi/HIV counselling, participants in the intervention arm will also attend a 2-hour educational class and will receive monthly SMS/text messages to reinforce the content of the class.
Primary Outcome Measure Information:
Title
Incident sexually transmitted infections
Description
Biological testing for syphilis, chlamydia trachomatis, neisseria gonorrhea, mycoplasma genitalium, and HIV
Time Frame
12 months
Title
Acceptability of the intervention
Description
participant feedback and rating of the intervention session
Time Frame
immediately after the intervention
Secondary Outcome Measure Information:
Title
Number of sexual partners
Description
self-report by questionnaire
Time Frame
12 months
Title
Proportion of sexual encounters protect by condom use
Description
self-report by questionnaire
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Change in Knowledge about STIs, HIV and prevention: post-intervention
Description
Completion of a 20-item standardized questionnaire on STI/HIV transmission, symptoms, and prevention methods
Time Frame
Baseline and immediately after the intervention
Title
Change in Knowledge about STIs, HIV and prevention: retention at 6 months
Description
Completion of a 20-item standardized questionnaire on STI/HIV transmission, symptoms, and prevention methods
Time Frame
Baseline, immediately after the intervention, and at 6 months
Title
Change in Knowledge about STIs, HIV and prevention: retention at 12 months
Description
Completion of a 20-item standardized questionnaire on STI/HIV transmission, symptoms, and prevention methods
Time Frame
Baseline, immediately after the intervention, and at 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18 - 30 years Army active duty or Army medical beneficiary Eligible to receive care at a military healthcare clinic for at least 12 months from enrollment HIV negative Not scheduled for military deployment or transfer within 3 months of enrolment Not pregnant, regardless of marital status Not trying to become pregnant or impregnate a partner, regardless of marital status Be classified as "high risk" either through a positive STI diagnosis in the last 180 days or has had STI screening during this timeframe. Self reports vaginal, oral, and/or anal sexual contact in the last 30 days. Exclusion Criteria: Under 18 or over 30 years of age Not Army active duty or Army medical beneficiary Not eligible to receive care at a military healthcare clinic for study duration (next 12 months) HIV positive Military deployment or transfer scheduled within 3 months of enrollment Are pregnant, regardless of marital status Are trying to become pregnant or impregnate someone, regardless of marital status Has not had a positive STI diagnosis or STI screening within the last 180 days Does not self-report vaginal, anal, and/or oral sexual contact in the last 30 days
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Heather Follen, CCRC
Phone
253.320.4397
Email
heather.l.follen.ctr@health.mil
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tatjana Calvano, MD
Organizational Affiliation
Madigan Army Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ft. Bragg
City
Fayetteville
State/Province
North Carolina
ZIP/Postal Code
28310
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shannon Clark
Phone
910-907-8438
Email
shannon.clark8.ctr@mail.mil
First Name & Middle Initial & Last Name & Degree
Maureen Sevilla, PAC
Facility Name
Madigan Army Medical Center
City
Tacoma
State/Province
Washington
ZIP/Postal Code
98431
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heather Follen, AA
Phone
253-320-4397
Email
heather.l.follen.ctr@mail.mil

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Requests for data sharing may be considered on a case-by-case basis
Citations:
PubMed Identifier
35366848
Citation
Kunz A, Moodley A, Colby DJ, Soltis M, Robb-McGrath W, Fairchok A, Faestel P, Jungels A, Bender AA, Kamau E, Wingood G, DiClemente R, Scott P. Feasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family members. BMC Public Health. 2022 Apr 2;22(1):640. doi: 10.1186/s12889-022-13096-x.
Results Reference
derived

Learn more about this trial

STI/HIV Intervention Behavioral Intervention Program

We'll reach out to this number within 24 hrs